Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5899 USD | +1.20% | -0.02% | +11.30% |
Apr. 16 | BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 29 | BioNexus Gene Lab Corp. Provides Information to Shareholders | CI |
Business Summary
Number of employees: 30
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chemrex
99.8
%
| 11 | 99.1 % | 10 | 99.8 % | -10.03% |
MRNA Scientific Malaysia
0.2
%
| 0 | 0.9 % | 0 | 0.2 % | -74.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Malaysia
100.0
%
| 11 | 100.0 % | 10 | 100.0 % | -10.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Keong Yap
BRD | Director/Board Member | 68 | 22-03-06 |
Wei Foong Lim
BRD | Director/Board Member | 48 | Dec. 10 |
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,667,663 | 6,294,165 ( 35.63 %) | 0 | 35.63 % |
Company contact information
BioNexus Gene Lab Corp.
Tower B, Vertical Business Suite Bangsar South, 8 Jalan Kerinchi
59200, Kuala Lumpur
+60 1 307 241 6898
http://www.bionexusgenelab.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+9.43% | 10.3M | |
+28.66% | 49.18B | |
+0.96% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.38% | 26.09B | |
-22.60% | 18.71B | |
+8.07% | 13.26B | |
+32.17% | 12.32B | |
-0.42% | 11.99B |
- Stock Market
- Equities
- BGLC Stock
- Company BioNexus Gene Lab Corp.